Pricing Log in Create free account

Cassava Sciences, Inc. (FLNA) vs Seres Therapeutics, Inc. (MCRB)

Cassava Sciences, Inc. and Seres Therapeutics, Inc. are both Biotechnology companies. Cassava Sciences, Inc. and Seres Therapeutics, Inc. are of similar size ($21.8M and $20.8M). Cassava Sciences, Inc. grew revenue faster over the last twelve months: 277.6% against −98.3%. Cassava Sciences, Inc. has the higher net margin (0.00% vs −2,209.6%) and the higher return on invested capital (0.00% vs −1,267.8%). Across the 14 metrics below, Cassava Sciences, Inc. leads on 11 and Seres Therapeutics, Inc. on 3.

Valuation

Metric FLNA MCRB Biotechnology median
P/E n/m n/m 10.60
P/S n/m 9.25 9.40
P/B 0.34 0.92 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 1.35 n/m 0.66
EV/Sales n/m 49.24 9.02
Earnings yield (193.33%) (253.88%) (32.88%)
Free cash flow yield (135.06%) (323.94%) (23.13%)

Profitability

Metric FLNA MCRB Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (3,656.89%) 0.00%
Net margin 0.00% (2,209.55%) 0.00%
Free cash flow margin 0.00% (2,997.74%) 0.00%
Return on equity (55.78%) (144.35%) (51.96%)
Return on assets (35.34%) (44.85%) (46.06%)
Return on invested capital 0.00% (1,267.77%) 0.00%

Growth

Metric FLNA MCRB Biotechnology median
Revenue growth (TTM) 277.58% (98.33%) 6.76%
EPS growth (last fiscal year) (28.77%) 0.00% 29.88%
Revenue growth, 5-year CAGR — (53.03%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FLNA MCRB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.08 1.65 4.97
Net debt to EBITDA 1.01 0.51 1.01

Dividend

Metric FLNA MCRB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric FLNA MCRB Biotechnology median
Market cap 21.79m 20.78m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack